In lung cancer, correlation of TAMs with outcome depends on TAMs subsets and intratumoral distribution, as M2 type (CD163+) and stromal TAMs are correlated with poor outcome, while M1 type (HLA-DR+) and intraepithelial TAMs are correlated with favorable outcome [30]. This evidence concerns the gene CD163 and lung cancer.